• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neurol Res . Increased prevalence of mild myopathic changes in the post-COVID-19 duration

tetano

Editor, Senior Moderator
Neurol Res


. 2023 Sep 20;1-8.
doi: 10.1080/01616412.2023.2258034. Online ahead of print. Increased prevalence of mild myopathic changes in the post-COVID-19 duration

Ayşegül Gündüz[SUP] 1 [/SUP], Merve Hazal Ser[SUP] 1 [/SUP], Fatma Zehra Çalıkuşu[SUP] 1 [/SUP], Uygur Tanrıverdi[SUP] 1 [/SUP], Hikmet Abbaszade[SUP] 1 [/SUP], Sena Hakyemez[SUP] 2 [/SUP], I Lker İnanç Balkan[SUP] 2 [/SUP], Rıdvan Karaali[SUP] 2 [/SUP], Fatih Kantarcı[SUP] 3 [/SUP], Nurten Uzun Adatepe[SUP] 1 [/SUP]



Affiliations
Abstract

Objective: There are reports of peripheral nerve and muscle involvement during or after coronavirus disease 2019 (COVID-19), even following a mild infection. Here, we aimed to analyze the objective findings regarding peripheral nerve, neuromuscular junction, and muscle function using electrophysiology in patients with a previous COVID-19 infection.
Methods: All consecutive patients with a history of COVID-19 were questioned for post-COVID-19 duration-related neurological complaints via Composite Autonomic Symptom Score-31 (COMPASS-31), modified Toronto Neuropathy score (mTORONTO), and Fatigue Severity Scale (FSS). Patients were dichotomized into two groups based on their scores in the questionnaire. Group 1 (patients with high scores in any area of the questionnaire) and Group 2 (patients with normal scores in all sections of the questionnaire). In the second step, Group 1 was invited to a preplanned hospital visit for electrophysiological analysis, including nerve conduction studies, repetitive nerve stimulation, needle electromyography (EMG), quantitative motor unit potential analysis (qMUP), and single fiber EMG. We included 106 patients in the study. According to the questionnaire, 38 patients constituted Group 1, and 68 formed Group 2.
Results: Of the 38 patients, 14 accepted and underwent preplanned electrophysiological examinations. Needle EMG revealed small, short, polyphasic MUPs with early recruitment, and qMUP analysis demonstrated an increased percentage of polyphasic potentials in three patients. The examinations in other patients were unremarkable.
Conclusions: The high prevalence of complaints and objective myopathic findings in our cohort implicated the role of muscle involvement in the post-COVID-19 duration. Considering the socioeconomic and psychological burden of the post-COVID-19 duration among individuals and societies, a better understanding of the symptoms and myopathy is warranted.

Keywords: Post-COVID-19 duration; fatigue; myogenic motor unit potentials; myopathy; quantitative motor unit action potential analysis.

 
Back
Top Bottom